Clinical Trials Logo

Epilepsy in Pregnancy clinical trials

View clinical trials related to Epilepsy in Pregnancy.

Filter by:
  • None
  • Page 1

NCT ID: NCT04117425 Recruiting - Clinical trials for Epilepsy in Pregnancy

Pharmacokinetic and Placental Transfer of Levetiracetam

EPICEINTE
Start date: April 20, 2022
Phase: N/A
Study type: Interventional

Hypotheses: The treatment of epilepsy during pregnancy is difficult because of the risk of anti-epileptic drugs on the one hand and the risk of destabilization of epilepsy in the mother on the other hand. There is limited data on the pharmacokinetics (concentration study) and pharmacodynamics (efficacy and toxicity effects study) of levetiracetam in pregnant women. The few studies focus on few women and show very strong interindividual variability and a tendency to decrease total concentrations. Main objective: To develop a population pharmacokinetic model of levetiracetam during pregnancy. After the study, this model could be used to propose dose adjustments to maintain stable concentrations in pregnant women throughout pregnancy. Secondary objectives: - Describe placental transfer during childbirth and during a medical termination of pregnancy - Link the concentration and its variation in the individual to the effects of treatment